These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2215261)

  • 21. An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.
    Lala PK; McKenzie IF
    Immunology; 1982 Dec; 47(4):663-77. PubMed ID: 6982847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
    Hammou JC; Fella C; Vacant J
    Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
    [No Abstract]   [Full Text] [Related]  

  • 23. Current condition and prognosis of tumor immunotherapy: a second opinion.
    Mastrangelo MJ; Berd D; Maguire HC
    Cancer Treat Rep; 1984 Jan; 68(1):207-19. PubMed ID: 6362864
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibody-defined human lung cell surface protein antigens.
    Mazauric T; Mitchell KF; Letchworth GJ; Koprowski H; Steplewski Z
    Cancer Res; 1982 Jan; 42(1):150-4. PubMed ID: 7053844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
    Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
    Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoperoxidase staining in tumor marker distribution studies in cytologic specimen.
    Coleman DV; To A; Ormerod MG; Dearnaley DP
    Acta Cytol; 1981; 25(3):205-6. PubMed ID: 7020314
    [No Abstract]   [Full Text] [Related]  

  • 27. Akaike's Information Criterion and Recent Developments in Information Complexity.
    Bozdogan H
    J Math Psychol; 2000 Mar; 44(1):62-91. PubMed ID: 10733858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surface membrane markers (clusters of differentiation) used in dermatopathology (1): The lymphocyte markers].
    Ingen-Housz-Oro S; Ortonne N
    Ann Dermatol Venereol; 2015 Oct; 142(10):598-606. PubMed ID: 26169897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
    Srougi M; Alves VA; Gayotto LC; Arap S
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cell surface marker (CD-phenotype)].
    Takeshita A
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():293-8. PubMed ID: 17476749
    [No Abstract]   [Full Text] [Related]  

  • 31. Bayesian information criterion for longitudinal and clustered data.
    Jones RH
    Stat Med; 2011 Nov; 30(25):3050-6. PubMed ID: 21805487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous feature selection and clustering using mixture models.
    Law MH; Figueiredo MA; Jain AK
    IEEE Trans Pattern Anal Mach Intell; 2004 Sep; 26(9):1154-66. PubMed ID: 15742891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An introduction to tumour immunology.
    Keith J
    Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies.
    Rasmussen BB; Pedersen BV; Thorpe SM; Hilkens J; Hilgers J; Rose C
    Cancer Res; 1985 Mar; 45(3):1424-7. PubMed ID: 3971385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 36. Network information criterion-determining the number of hidden units for an artificial neural network model.
    Murata N; Yoshizawa S; Amari S
    IEEE Trans Neural Netw; 1994; 5(6):865-72. PubMed ID: 18267861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CA 19-9 and cancer of the pancreas. Critical review of the literature].
    Delcourt A
    Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822
    [No Abstract]   [Full Text] [Related]  

  • 38. [Surface antigens of oropharyngeal neoplasms (preliminary report)].
    Nasyrov VA; Spure ZhZh; Chireshkin DG
    Vestn Otorinolaringol; 1981; (2):58-60. PubMed ID: 7013243
    [No Abstract]   [Full Text] [Related]  

  • 39. [The current concept of tumor markers in oncological urology--cell surface markers].
    Ianev V; Kumanov Kh; Tsvetkov D; Ormanov I
    Khirurgiia (Sofiia); 1989; 42(4):14-7. PubMed ID: 2585974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data analysis of the Second International Workshop on Small Cell Lung Cancer Antigens.
    Gilks WR; Oldfield L; Wild P
    Br J Cancer Suppl; 1991 Jun; 14():3-9. PubMed ID: 1645567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.